Biventricular Arrhythmogenic Cardiomyopathy: a paradigmatic case

We present a case of arrhythmogenic cardiomyopathy with biventricular involvement and strong arrhythmic substrate, highlighting the need to consider more than a single diagnostic option when facing arrhythmic presentations in young patients and the growing contribution provided by the genetic laboratory and contrast CMR to clinical management.

[1]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[2]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[3]  M. Simpson,et al.  Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy , 2005, Circulation.

[4]  M. P. van den Berg,et al.  A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy , 2009, Human mutation.

[5]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[6]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[7]  Juerg Schwitter,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[8]  Alexandros Patrianakos,et al.  Left dominant arrhythmogenic cardiomyopathy: a morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion. , 2013, Journal of electrocardiology.

[9]  L. Monserrat,et al.  Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[11]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[12]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[13]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[14]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[15]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.